A, O., M, W., J, O., S, M., R, T., H, K., . . . Y, D. (2023). ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study. Annals of surgical oncology, 30(9), 5895. https://doi.org/10.1245/s10434-023-13687-x
Chicago Style (17th ed.) CitationA, Okamura, et al. "ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study." Annals of Surgical Oncology 30, no. 9 (2023): 5895. https://doi.org/10.1245/s10434-023-13687-x.
MLA (9th ed.) CitationA, Okamura, et al. "ASO Author Reflections: Neoadjuvant Chemotherapy or Neoadjuvant Chemoradiotherapy for Patients with Esophageal Squamous Cell Carcinoma: Real-World Data Comparison from a Japanese Nationwide Study." Annals of Surgical Oncology, vol. 30, no. 9, 2023, p. 5895, https://doi.org/10.1245/s10434-023-13687-x.